Article
Lovastatin suppresses the aberrant tau phosphorylation from FTDP-17 mutation and okadaic acid-induction in rat primary neurons.
Neuroscience - 21 May 2015
Li R, Xu D-E, Ma T
Abstract excerpt
Statins are a class of cholesterol-lowering drugs and have been suggested therapeutic use for neurodegenerative diseases including Alzheimer's disease (AD). Our recent studies revealed a neuronal protective effect of lovastatin (LOV) from N-methyl-d-aspartic acid (NMDA) excitotoxicity. The neurop...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
